DS
Therapeutic Areas
Syncromune Pipeline
| Drug | Indication | Phase |
|---|---|---|
| SYNC-T | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Phase 2 |
| SYNC-T Platform | Metastatic Non-Small Cell Lung Cancer (mNSCLC) | Preclinical/Research |
| Drug | Indication | Phase |
|---|---|---|
| SYNC-T | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Phase 2 |
| SYNC-T Platform | Metastatic Non-Small Cell Lung Cancer (mNSCLC) | Preclinical/Research |